Delivery Order SPE2DB22D3016-SPE2DB26FAAY9
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,186.15 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,568.99 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,424.62 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a $10,845.73 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 30, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,846.23 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed price, non-set-aside contract with performance location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency (DLA) awarded a $5,575.44 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus continuous glucose monitoring sensors, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,008.65 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on April 25, 2025, with an ultimate completion date of April 28, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,368.94 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 17, 2025, with completion expected by October 20, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The sensors will be supplied from the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,709.92 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAY9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,665.21 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 30, 2025, with an ultimate completion date of October 31, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in meeting federal medical procurement requirements through multiple competitively awarded contracts with the Defense Logistics Agency. The company's federal portfolio includes delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across various therapeutic domains. This particular award for continuous glucose monitoring sensors supports the Defense Health Agency and other federal healthcare systems' medical supply needs through the company's established global pharmaceutical support infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 10/30/25 |